Découvrez des technologies à haut potentiel d’impact ainsi que des solutions émergentes.
Chaque fiche du portfolio ARN comprend:
- Proposition complète et statistiques essentielles
- Fonds amassés
- Jalons
- Opportunités d’affaires
- Analyse de marché
- Membre de l’équipe
Portefolio ARN complet
PDF – 12 pages – Anglais
INTÉRESSÉ À INVESTIR ?
Contenu du portefolio
Veuillez noter que les documents sont présentement disponibles uniquement en anglais.
Propositions à haut potentiel impact
- Espoir Biosciences : Reactivating the Brain’s Repair Mechanisms to Reverse Neurodegeneration
- Nanofacile™ Symphony Kit : Accelerating RNA therapy discovery & development
- Cell-Immune Pharma : Engineering Human-Derived T-Cell Solutions to Supercharge Vaccines & Immunotherapies
Solutions émergentes
- RNABioPrecision: Reprogramming disease networks with synthetic RNA molecules inspired by natural microRNAs
- Chemically Modified CRISPR crRNA for Advanced Gene Editing Applications
- RNOVA Tx: Innovative antisense strategies targeting SRSF3 to reprogram immune response in neurodegenerative disorders
- Prevention of Cancer∕Metastasis Through an Antibody-Oligo-Conjugate (AOC) Platform
- Layer-by-Layer Lipid Nanoparticles for Enhanced Gene and Drug Delivery
- DNA-Encoded Functionalized Aptamers
- Smart Anti-Infective Antisense Strategy and Molecules
- Novel Treatment for Microvessel Rarefaction
Propositions à haut potentiel d’impact
Espoir Biosciences
Reactivating the Brain’s Repair Mechanisms to Reverse Neurodegeneration
Nanofacile™ Symphony Kit
Accelerating RNA therapy discovery & development
Cell-Immune Pharma (CIP)
Engineering Human-Derived T-Cell Solutions to Supercharge Vaccines & Immunotherapies
Solution émergentes
RNABioPrecision: Reprogramming disease networks with synthetic RNA molecules inspired by natural microRNAs
IRIC-UdeM
Chemically Modified CRISPR crRNA for Advanced Gene Editing Applications
McGill
RNOVA Tx: Innovative antisense strategies targeting SRSF3 to reprogram immune response in neurodegenerative disorders
Université de Laval
Prevention of Cancer∕Metastasis Through an Antibody-Oligo-Conjugate (AOC) Platform
IRCM
Layer-by-Layer Lipid Nanoparticles for Enhanced Gene and Drug Delivery
CHU Sainte-Justine-UdeM
DNA-Encoded Functionalized Aptamers
McGill
Smart Anti-Infective Antisense Strategy and Molecules
McGill
Novel Treatment for Microvessel Rarefaction
CrCHUM